China¿s New Rural Cooperative Medical Scheme - Liu, Dan
60,85 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
0 °P sammeln
  • Gebundenes Buch

The New Cooperative Medical Scheme (NCMS) was implemented in 2003 in response to the poor state of health care in rural China. It holds the primary objective of insuring rural residents against catastrophic health expenses, protecting them from impoverishment caused by medical expenses. The objective of this study, therefore, is to explore variation in the determinants of household enrolment in this scheme and the impact of enrolment on health care utilization and medical expenditures in three large geographic regions in China and further to simulate the reimbursement package design in order…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The New Cooperative Medical Scheme (NCMS) was implemented in 2003 in response to the poor state of health care in rural China. It holds the primary objective of insuring rural residents against catastrophic health expenses, protecting them from impoverishment caused by medical expenses. The objective of this study, therefore, is to explore variation in the determinants of household enrolment in this scheme and the impact of enrolment on health care utilization and medical expenditures in three large geographic regions in China and further to simulate the reimbursement package design in order to achieve better financing protection and policy effectiveness.
Autorenporträt
Dan Liu is currently Research Fellow at the Mannheim Institute of Public Health, Social and Preventive Medicine, University of Heidelberg (Germany). She studied at Sichuan Agricultural University (China) and completed her PhD at the University of Bonn (Germany). Her research interest lies in the area of development economics, with a focus on health domain, including health care demand, health financing, health risk management, and the impact evaluation of policy. In recent years, she has extended her studies related to health economics, ranging from the economic evaluation of health technology to health intervention programs.